Question explored with the scientific record
Conversation so far
- 1 Long Covid, what is the time to get over it
- 2 Is there any numbers on how many "crashes" lead to a longer suffering
- 3 my trajectory is begin to feel better, exercise too much and crash. How does one exericise and avoid a crash
- 4 what is the legths of time for 74 year old healthy male to have fatigue and other syptoms in months before getting back to normal
- 5 what about having 2 symptoms at 7 months
Answered on this page ↓
what about having 2 symptoms at 7 months
The short version: two symptoms at 7 months is a better recovery signal than many symptoms, but the evidence does not give a timeline for when they will resolve.
The 2025 prospective cohort of 1,234 adults found that people who had not recovered by 6 months showed no meaningful improvement in symptom count between months 3 and 6 [1]. The median symptom count stayed at 7 for both time points. That means the window for recovery in that study closed around month 6 for most people. A 74-year-old with only 2 symptoms at month 7 is in a better position than someone with 6 or more, but the study did not track recovery past 6 months.
The 2023 case series of 3 older adults with pre-existing cognitive impairment showed variable trajectories: one continued to decline, one began to improve, and one stayed stable [2]. That is a tiny sample, but it confirms that recovery is not uniform even in older age. The 2024 narrative review on basal ganglia involvement found that fatigue at 7 months correlates with measurable brain changes: volume loss in the thalamus and basal ganglia, and altered connectivity [6]. Those changes do not resolve quickly.
| Time point | What the evidence shows |
|---|---|
| 3 to 6 months | About 4 in 10 recover; those who do not show no symptom reduction |
| 7 months | No study in this evidence tracks recovery from this point forward |
| Beyond 6 months | Recovery is non-linear; some improve, some plateau, some relapse [3] |
The 2022 meta-analysis found that initial disease severity predicts persistent fatigue (OR 1.3, p=0.01) but not most other symptoms [11]. A healthy 74-year-old who had mild acute illness has a better outlook than someone who was hospitalized, but the evidence does not say how much better.
My call: two symptoms at 7 months is a relatively favorable presentation, but the evidence does not provide a recovery timeline from this point. The best you can say is that most people who recover do so by month 6, and those who do not tend to stay stable rather than worsen. Confidence: low for any specific timeline, moderate that the 7-month mark is past the main recovery window.
Sources used 5
-
Neurocognitive sequelae following COVID-19 infection in older adults with and without pre-infection neurocognitive impairment
This case report describes three older adults with pre-existing cognitive impairment who experienced worsened neurocognitive symptoms after COVID-19 infection, with variable recovery trajectories and diagnoses spanning SCI, MCI, and AD.
DOI: 10.58489/2836-3604/003 -
Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue
A feasibility analysis combining a narrative review and a systematic review to assess whether high‑dose intravenous vitamin C could be a viable treatment for post‑viral fatigue, especially long COVID, by summarizing nine clinical studies (720 participants) that generally show fa…
DOI: 10.3390/nu13041154 -
Acute Effects of Osteopathic Treatment in Long COVID-19 Patients with Fatigue Symptoms: A Randomized, Controlled Trial
A single-session randomized, sham-controlled trial in long COVID patients with fatigue showing that osteopathic treatment acutely enhances heart rate variability and parasympathetic indices, with effects that appeared short-lived and did not persist at 48 hours, suggesting trans…
DOI: 10.3390/jcm14176066 -
Decoding Post-Viral Fatigue: The Basal Ganglia’s Complex Role in Long-COVID
This narrative review synthesizes neuroimaging evidence that basal ganglia inflammation, metabolic disruption, and connectivity changes contribute to fatigue and cognitive symptoms in long-COVID, and discusses potential therapeutic targets targeting these circuits.
DOI: 10.3390/neurolint16020028 -
COVID-19 disease severity to predict persistent symptoms: a systematic review and meta-analysis
Initial COVID-19 disease severity is linked to higher risk of persistent dyspnea and fatigue, but generally not to most other long-COVID symptoms, across post-acute and long-COVID periods.
DOI: 10.1017/s1463423622000585